Last updated on March 2012

C. diff


Brief description of study

C. diff

Detailed Study Description

Let’s Try to Break the Cycle

If a patient has C. diff now, they have up to a 60% chance of having C. diff again.*

The MODIFY Study in testing the safety, effectiveness and tolerability of an investigational drug to see if it can help prevent C. diff reoccurrences.

Participants will receive study-related exams and study drug at no charge. There are risks associated with participation in this clinical research study. They study doctor will explain the study requirements, possible benefits, and potential risks to you before you decide to participate.

Patient Inclusion Criteria:
Eligible participants must:

  • Be at least 18 years of age
  • Have a diagnosis of C. diff (including a positive stool test)

Clinical Study Identifier: TX135619

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Lorraine Breuer

Parker Jewish Institute
New Hyde Park, NY USA
  Connect »